Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mean free path and Mean free time01:22

Mean free path and Mean free time

5.1K
Consider the gas molecules in a cylinder. They move in a random motion as they collide with each other and change speed and direction. The average of all the path lengths between collisions is known as the "mean free path."
5.1K
Path Between Thermodynamics States01:21

Path Between Thermodynamics States

4.0K
Consider the two thermodynamic processes involving an ideal gas that are represented by paths AC and ABC in Figure 1:
4.0K
Interference: Path Lengths01:10

Interference: Path Lengths

2.2K
Consider two sources of sound, that may or may not be in phase, emitting waves at a single frequency, and consider the frequencies to be the same.
Two special sources may be considered when they are in phase. This can be easily achieved by feeding the two sources from the same source. An example would be synchronizing the two speakers by feeding them with the same source, such as the sound waves produced by a tuning fork. This setup ensures that the two sources have the same frequency and are...
2.2K
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion03:48

Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion

31.3K
Although gaseous molecules travel at tremendous speeds (hundreds of meters per second), they collide with other gaseous molecules and travel in many different directions before reaching the desired target. At room temperature, a gaseous molecule will experience billions of collisions per second. The mean free path is the average distance a molecule travels between collisions. The mean free path increases with decreasing pressure; in general, the mean free path for a gaseous molecule will be...
31.3K
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.

The Pediatric infectious disease journal·2026
Same author

TNFRSF13B Common Variants Enhance Antibody-Dependent Complement Activation and Susceptibility to Acute Respiratory Distress Syndrome Following Respiratory Viral Infection.

medRxiv : the preprint server for health sciences·2026
Same author

Restoration of ovarian endocrine function with encapsulated immune-isolated human ovarian xenograft in ovariectomized mice.

Science advances·2026
Same author

Xenotransplantation: From research to trial to practice.

Human immunology·2025
Same author

A preclinical pig model of Angelman syndrome mirrors the early developmental trajectory of the human condition.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Author Correction: Intestinal non-canonical NFκB signaling shapes the local and systemic immune response.

Nature communications·2025

Related Experiment Video

Updated: Feb 1, 2026

Quantification of Circulating Pig-Specific DNA in the Blood of a Xenotransplantation Model
07:34

Quantification of Circulating Pig-Specific DNA in the Blood of a Xenotransplantation Model

Published on: September 22, 2020

4.5K

Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Jeffrey L Platt1, Marilia Cascalho1, Jorge A Piedrahita2

  • 1Surgery, Microbiology & Immunology, and Transplantation Biology, University of Michigan, Ann Arbor, Michigan.

ILAR Journal
|December 13, 2018
PubMed
Summary

Xenotransplantation, using animal organs for humans, faces biological barriers but shows promise. Genetic engineering in pigs is improving outcomes and enabling new approaches like reverse xenotransplantation.

Keywords:
adaptive immunityclinical xenotransplantationgene editinginnate immunitymolecular incompatibilitynonhuman primatereverse xenografttransgenic pigxenotransplantationzoonosis

More Related Videos

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
11:18

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat

Published on: September 12, 2014

15.8K
Author Spotlight: Advancing Cancer Therapeutics Using Tumor Xenotransplantation in Zebrafish
06:10

Author Spotlight: Advancing Cancer Therapeutics Using Tumor Xenotransplantation in Zebrafish

Published on: July 12, 2024

1.9K

Related Experiment Videos

Last Updated: Feb 1, 2026

Quantification of Circulating Pig-Specific DNA in the Blood of a Xenotransplantation Model
07:34

Quantification of Circulating Pig-Specific DNA in the Blood of a Xenotransplantation Model

Published on: September 22, 2020

4.5K
Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
11:18

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat

Published on: September 12, 2014

15.8K
Author Spotlight: Advancing Cancer Therapeutics Using Tumor Xenotransplantation in Zebrafish
06:10

Author Spotlight: Advancing Cancer Therapeutics Using Tumor Xenotransplantation in Zebrafish

Published on: July 12, 2024

1.9K

Area of Science:

  • Biomedical Engineering
  • Transplantation Science
  • Immunology

Background:

  • Xenotransplantation (animal-to-human organ transplantation) offers a solution to human organ scarcity.
  • Allotransplantation (human-to-human) success fueled interest in xenotransplantation.
  • Significant biological barriers hinder clinical xenotransplantation.

Purpose of the Study:

  • To explore genetic engineering as a method to overcome xenotransplantation barriers.
  • To review advancements in genetically modifying pigs for xenotransplantation.
  • To discuss the potential of reverse xenotransplantation using human stem cells in pigs.

Main Methods:

  • Review of genetic engineering techniques applied to large animals, particularly pigs.
  • Analysis of experimental xenograft outcomes in nonhuman primates.
  • Examination of conditions supporting human stem cell differentiation in pigs.

Main Results:

  • Genetic engineering has significantly improved experimental xenograft outcomes.
  • Development of reverse xenotransplantation models using pigs.
  • Progress in overcoming immune and biological incompatibilities.

Conclusions:

  • Genetic engineering holds potential for advancing xenotransplantation and reverse xenotransplantation.
  • Current models require further development for clinical application.
  • Addressing biological barriers remains crucial for successful xenotransplantation.